Drug Shortage Report for SANDOZ CEFPROZIL
| Report ID | 73849 |
| Drug Identification Number | 02302179 |
| Brand name | SANDOZ CEFPROZIL |
| Common or Proper name | CEFPROZIL |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | CEFPROZIL |
| Strength(s) | 250MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | J01DC |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | 2019-04-30 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | 2021-07-23 |
| Shortage status | Resolved |
| Updated date | 2023-11-17 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2023-11-17 | French | Compare |
| v4 | 2023-11-17 | English | Compare |
| v3 | 2019-05-01 | English | Compare |
| v2 | 2019-01-30 | French | Compare |
| v1 | 2019-01-30 | English | Compare |
Showing 1 to 5 of 5